Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Recombinant cytokine bioconjugates with degradable nanogel substrates for macrophage immunotherapy

Acta Biomaterialia(2025)10.1016/j.actbio.2025.05.066Source: DataRank Database

Recombinant cytokine bioconjugates with degradable nanogel substrates for macrophage immunotherapy is a research paper published in Acta Biomaterialia (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.64)OA: greenTopics (40)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Chloé Catelain ORCID,Harsh A. Joshi ORCID,Danuta Radyna,John R. Clegg ORCID,Rana Ajeeb

Live enrichment

PubMed:40449706 PMC:PMC12927496 OpenAlex:https://openalex.org/W4410856615

NIH National Institute of General Medical Sciences

Grant: R35GM150970

National Institutes of Health National Cancer Institute

Grant: P30CA225520

National Institutes of Health

Stephenson Cancer Center

Harold Hamm Diabetes Center, OU Health

University of Oklahoma Health Sciences Center

The University of Oklahoma

FWCI

2.64

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12927496/

publisherhttps://api.elsevier.com/content/article/PII:S1742706125004015?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1742706125004015?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.actbio.2025.05.066

Fields of Study

Immune cells in cancerImmunotherapy and Immune ResponsesChemokine receptors and signalingAnimalsMiceMacrophagesNanogelsRAW 264.7 CellsImmunotherapyCytokinesRecombinant ProteinsPolyethyleneiminePolyethylene Glycols

MeSH Terms

RAW 264.7 CellsNanogelsAnimalsImmunotherapyMacrophagesPolyethylene GlycolsPolyethyleneimineRecombinant ProteinsCytokinesMice

Keywords

NanogelMaterials scienceImmunotherapyCytokineRecombinant DNAMacrophageBiomedical engineeringCancer researchImmunologyNanotechnologyImmune systemDrug deliveryMedicineChemistryBiochemistryIn vitroBioconjugation

Recombinant cytokine bioconjugates with degradable nanogel substrates for macrophage immunotherapy

FAIR Checklist

Authors (5)

Funding (7 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)